
HBS Reporting
Fauci says vast majority of vaccinated Americans should get a COVID-19 booster
-
HBS Reporting
Russia says July was the deadliest month of the pandemic
Aug 30, 2021MOSCOW (Reuters) – Russia saw the highest monthly coronavirus death toll of the pandemic in July,...
-
HBS Reporting
Germany will offer Africa up to 70 million COVID-19 doses, Merkel says
Aug 30, 2021BERLIN (Reuters) – Germany will make up to 70 million doses of COVID-19 vaccine available to...
-
HBS Reporting
U.S. officials weigh shorter timeline for COVID booster shots -Biden
Aug 30, 2021WASHINGTON (Reuters) -Federal health authorities are discussing shortening the timeline for COVID-19 booster shots to allow...
-
HBS Reporting
Sydney hospitals erect emergency tents amid Delta surge
Aug 26, 2021SYDNEY (Reuters) – Two major hospitals in Sydney’s west, the epicentre of Australia’s coronavirus outbreak, set...
-
HBS Reporting
Britain says no decision yet on COVID-19 vaccine for 12 to 15 year old
Aug 26, 2021Aug 25 (Reuters) – Britain’s Health Department said it has not made any decision on COVID-19...
-
HBS Reporting
U.S. plans COVID-19 booster shots at six months instead of eight – WSJ
Aug 26, 2021Aug 25 (Reuters) – U.S. health regulators could approve a third COVID-19 shot for adults beginning...
-
HBS Reporting
mRNA vaccines trigger backup immune response; some cancer drugs may help
Aug 26, 2021(Reuters) – Here is a summary of some recent studies on COVID-19. They include research that...
-
HBS Reporting
Heart inflammation risk boosted slightly by vaccine, more by COVID-19 – study
Aug 26, 2021(Reuters) – The use of Pfizer Inc and German partner BioNTech SE’s widely used COVID-19 vaccine...
-
HBS Reporting
Britons turn critical of government’s pandemic response
Aug 26, 2021LONDON, Aug 26 (Reuters) – The British public’s view of the government’s management of the coronavirus...
-
HBS Reporting
Novartis’s Kymriah does not meet primary endpoint in phase III study
Aug 24, 2021ZURICH, Aug 24 (Reuters) – Novartis ag (NOVN.S) said its Kymriah to treat aggressive B-cell non-Hodgkin...